-
1
-
-
39049192296
-
The origin of cancer metastasis
-
J. Carr and I. Carr: The origin of cancer metastasis. Can Bull Med Hist, 22(2), 353-358, (2005)
-
(2005)
Can Bull Med Hist
, vol.22
, Issue.2
, pp. 353-358
-
-
Carr, J.1
Carr, I.2
-
2
-
-
0030995179
-
Incidence and kinetics of distant metastases in patients with operable breast cancer
-
M. Kryj, B. Maciejewski, H. R. Withers and J. M. Taylor: Incidence and kinetics of distant metastases in patients with operable breast cancer. Neoplasma, 44(1), 3-11, (1997) (Pubitemid 27181811)
-
(1997)
Neoplasma
, vol.44
, Issue.1
, pp. 3-11
-
-
Kryj, M.1
Maciejewski, B.2
Withers, H.R.3
Taylor, J.M.G.4
-
3
-
-
77954740501
-
Metastatic behavior of breast cancer subtypes
-
Jul 10
-
H. Kennecke, R. Yerushalmi, R. Woods, M. C. Cheang, D. Voduc, C. H. Speers, T. O. Nielsen and K. Gelmon: Metastatic Behavior of Breast Cancer Subtypes. J Clin Oncol, 2010 Jul 10;28(20):3271-7.
-
(2010)
J Clin Oncol
, vol.28
, Issue.20
, pp. 3271-3277
-
-
Kennecke, H.1
Yerushalmi, R.2
Woods, R.3
Cheang, M.C.4
Voduc, D.5
Speers, C.H.6
Nielsen, T.O.7
Gelmon, K.8
-
4
-
-
27644437566
-
Endocrine therapy-current benefits and limitations
-
R. I. Nicholson and S. R. Johnston: Endocrine therapy-current benefits and limitations. Breast Cancer Res Treat, 93 Suppl 1S3-10, (2005)
-
(2005)
Breast Cancer Res Treat
, vol.93
, Issue.SUPPL. 1
-
-
Nicholson, R.I.1
Johnston, S.R.2
-
5
-
-
38049014517
-
Evolving nonendocrine therapeutic options for metastatic breast cancer: How adjuvant chemotherapy influences treatment
-
P. Conte, V. Guarneri and C. Bengala: Evolving nonendocrine therapeutic options for metastatic breast cancer: how adjuvant chemotherapy influences treatment. Clin Breast Cancer, 7(11), 841-849, (2007)
-
(2007)
Clin Breast Cancer
, vol.7
, Issue.11
, pp. 841-849
-
-
Conte, P.1
Guarneri, V.2
Bengala, C.3
-
6
-
-
46749126630
-
Response and resistance to the endocrine prevention of breast cancer
-
A. Howell, N. J. Bundred, J. Cuzick, D. C. Allred and R. Clarke: Response and resistance to the endocrine prevention of breast cancer. Adv Exp Med Biol, 617201-211, (2008)
-
(2008)
Adv Exp Med Biol
, pp. 617201-617211
-
-
Howell, A.1
Bundred, N.J.2
Cuzick, J.3
Allred, D.C.4
Clarke, R.5
-
7
-
-
42049121934
-
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
-
DOI 10.1210/er.2006-0045
-
G. Arpino, L. Wiechmann, C. K. Osborne and R. Schiff: Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance. Endocr Rev, 29(2), 217-233, (2008) (Pubitemid 351519691)
-
(2008)
Endocrine Reviews
, vol.29
, Issue.2
, pp. 217-233
-
-
Arpino, G.1
Wiechmann, L.2
Osborne, C.K.3
Schiff, R.4
-
8
-
-
11244250660
-
Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: New opportunities for therapy
-
DOI 10.1677/erc.1.00778
-
R. I. Nicholson, C. Staka, F. Boyns, I. R. Hutcheson and J. M. Gee: Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy. Endocr Relat Cancer, 11(4), 623-641, (2004) (Pubitemid 40065542)
-
(2004)
Endocrine-Related Cancer
, vol.11
, Issue.4
, pp. 623-641
-
-
Nicholson, R.I.1
Staka, C.2
Boyns, F.3
Hutcheson, I.R.4
Gee, J.M.W.5
-
9
-
-
0037373326
-
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells
-
DOI 10.1210/en.2002-220620
-
J. M. Knowlden, I. R. Hutcheson, H. E. Jones, T. Madden, J. M. Gee, M. E. Harper, D. Barrow, A. E. Wakeling and R. I. Nicholson: Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinology, 144(3), 1032-1044, (2003) (Pubitemid 36262870)
-
(2003)
Endocrinology
, vol.144
, Issue.3
, pp. 1032-1044
-
-
Knowlden, J.M.1
Hutcheson, I.R.2
Jones, H.E.3
Madden, T.4
Gee, J.M.W.5
Harper, M.E.6
Barrow, D.7
Wakeling, A.E.8
Nicholson, R.I.9
-
10
-
-
0035664786
-
Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer
-
H. Kurokawa and C. L. Arteaga: Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer. Clin Cancer Res, 7(12 Suppl), 4436s-4442s; discussion 4411s-4412s, (2001) (Pubitemid 34031593)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.12 SUPPL.
-
-
Kurokawa, H.1
Arteaga, C.L.2
-
11
-
-
26044478813
-
Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?
-
DOI 10.1158/1078-0432.CCR-05-0196
-
S. Tovey, B. Dunne, C. J. Witton, A. Forsyth, T. G. Cooke and J. M. Bartlett: Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer? Clin Cancer Res, 11(13), 4835-4842, (2005) (Pubitemid 41557203)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.13
, pp. 4835-4842
-
-
Tovey, S.1
Dunne, B.2
Witton, C.J.3
Forsyth, A.4
Cooke, T.G.5
Bartlett, J.M.S.6
-
12
-
-
0033001742
-
Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line
-
DOI 10.1038/sj.bjc.6690112
-
J. P. Parisot, X. F. Hu, M. DeLuise and J. R. Zalcberg: Altered expression of the IGF-1 receptor in a tamoxifenresistant human breast cancer cell line. Br J Cancer, 79(5-6), 693-700, (1999) (Pubitemid 29082092)
-
(1999)
British Journal of Cancer
, vol.79
, Issue.5-6
, pp. 693-700
-
-
Parisot, J.P.1
Hu, X.F.2
DeLuise, M.3
Zalcberg, J.R.4
-
13
-
-
33645234316
-
Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth
-
D. J. Britton, I. R. Hutcheson, J. M. Knowlden, D. Barrow, M. Giles, R. A. McClelland, J. M. Gee and R. I. Nicholson: Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. Breast Cancer Res Treat, 96(2), 131-146, (2006)
-
(2006)
Breast Cancer Res Treat
, vol.96
, Issue.2
, pp. 131-146
-
-
Britton, D.J.1
Hutcheson, I.R.2
Knowlden, J.M.3
Barrow, D.4
Giles, M.5
McClelland, R.A.6
Gee, J.M.7
Nicholson, R.I.8
-
14
-
-
24744471000
-
Evolving understanding of growth regulation in human breast cancer: Interactions of the steroid and peptide growth regulatory pathways
-
DOI 10.1093/jnci/dji288
-
C. A. Wilson and D. J. Slamon: Evolving understanding of growth regulation in human breast cancer: interactions of the steroid and peptide growth regulatory pathways. J Natl Cancer Inst, 97(17), 1238-1239, (2005) (Pubitemid 41535357)
-
(2005)
Journal of the National Cancer Institute
, vol.97
, Issue.17
, pp. 1238-1239
-
-
Wilson, C.A.1
Slamon, D.J.2
-
15
-
-
0036266077
-
Growth factor-induced cell motility in tumor invasion
-
DOI 10.1080/028418602753669481
-
A. Wells, J. Kassis, J. Solava, T. Turner and D. A. Lauffenburger: Growth factor-induced cell motility in tumor invasion. Acta Oncol, 41(2), 124-130, (2002) (Pubitemid 34557071)
-
(2002)
Acta Oncologica
, vol.41
, Issue.2
, pp. 124-130
-
-
Wells, A.1
Kassis, J.2
Solava, J.3
Turner, T.4
Lauffenburger, D.A.5
-
16
-
-
44949117528
-
Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells
-
DOI 10.1002/ijc.23465
-
Y. Ueno, H. Sakurai, S. Tsunoda, M. K. Choo, M. Matsuo, K. Koizumi, I. Saiki, P. Arora, B. D. Cuevas, A. Russo, G. L. Johnson and J. Trejo: Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells Int J Cancer, 123(2), 340-347, (2008) (Pubitemid 351842018)
-
(2008)
International Journal of Cancer
, vol.123
, Issue.2
, pp. 340-347
-
-
Ueno, Y.1
Sakurai, H.2
Tsunoda, S.3
Choo, M.-K.4
Matsuo, M.5
Koizumi, K.6
Saiki, I.7
-
17
-
-
47949089905
-
Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion
-
P. Arora, B. D. Cuevas, A. Russo, G. L. Johnson and J. Trejo: Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene, 27(32), 4434-4445, (2008)
-
(2008)
Oncogene
, vol.27
, Issue.32
, pp. 4434-4445
-
-
Arora, P.1
Cuevas, B.D.2
Russo, A.3
Johnson, G.L.4
Trejo, J.5
-
18
-
-
4344705051
-
Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib ('Iressa', ZD1839)
-
DOI 10.1023/B:CLIN.0000037697.76011.1d
-
S. Hiscox, L. Morgan, D. Barrow, C. Dutkowskil, A. Wakeling and R. I. Nicholson: Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839). Clin Exp Metastasis, 21(3), 201-212, (2004) (Pubitemid 39158497)
-
(2004)
Clinical and Experimental Metastasis
, vol.21
, Issue.3
, pp. 201-212
-
-
Hiscox, S.1
Morgan, L.2
Barrow, D.3
Dutkowski, C.4
Wakeling, A.5
Nicholson, R.I.6
-
19
-
-
28844494352
-
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation
-
DOI 10.1002/ijc.21355
-
S. Hiscox, W. G. Jiang, K. Obermeier, K. Taylor, L. Morgan, R. Burmi, D. Barrow and R. I. Nicholson: Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer, 118(2), 290-301, (2006) (Pubitemid 41779067)
-
(2006)
International Journal of Cancer
, vol.118
, Issue.2
, pp. 290-301
-
-
Hiscox, S.1
Jiang, W.G.2
Obermeier, K.3
Taylor, K.4
Morgan, L.5
Burmi, R.6
Barrow, D.7
Nicholson, R.I.8
-
20
-
-
33846811714
-
Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: Implications for tumour-stroma interactions
-
DOI 10.1677/erc.1.01270
-
S. Hiscox, N. J. Jordan, W. Jiang, M. Harper, R. McClelland, C. Smith and R. I. Nicholson: Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions. Endocr Relat Cancer, 13(4), 1085-1099, (2006) (Pubitemid 46212564)
-
(2006)
Endocrine-Related Cancer
, vol.13
, Issue.4
, pp. 1085-1099
-
-
Hiscox, S.1
Jordan, N.J.2
Jiang, W.3
Harper, M.4
McClelland, R.5
Smith, C.6
Nicholson, R.I.7
-
21
-
-
19944427176
-
Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iresa) in human breast and prostate cancer cells
-
DOI 10.1677/erc.1.00799
-
H. E. Jones, L. Goddard, J. M. Gee, S. Hiscox, M. Rubini, D. Barrow, J. M. Knowlden, S. Williams, A. E. Wakeling and R. I. Nicholson: Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells. Endocr Relat Cancer, 11(4), 793-814, (2004) (Pubitemid 40065552)
-
(2004)
Endocrine-Related Cancer
, vol.11
, Issue.4
, pp. 793-814
-
-
Jones, H.E.1
Goddard, L.2
Gee, J.M.W.3
Hiscox, S.4
Rubini, M.5
Barrow, D.6
Knowlden, J.M.7
Williams, S.8
Wakeling, A.E.9
Nicholson, R.I.10
-
22
-
-
34848826864
-
Epithelial - Mesenchymal and mesenchymal - Epithelial transitions in carcinoma progression
-
DOI 10.1002/jcp.21223
-
H. Hugo, M. L. Ackland, T. Blick, M. G. Lawrence, J. A. Clements, E. D. Williams and E. W. Thompson: Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol, 213(2), 374-383, (2007) (Pubitemid 47509716)
-
(2007)
Journal of Cellular Physiology
, vol.213
, Issue.2
, pp. 374-383
-
-
Hugo, H.1
Ackland, M.L.2
Blick, T.3
Lawrence, M.G.4
Clements, J.A.5
Williams, E.D.6
Thompson, E.W.7
-
24
-
-
59349115555
-
Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity
-
Y. Zhao and M. D. Planas-Silva: Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity. Cancer Lett, 275(2), 204-212, (2009)
-
(2009)
Cancer Lett
, vol.275
, Issue.2
, pp. 204-212
-
-
Zhao, Y.1
Planas-Silva, M.D.2
-
25
-
-
79959585615
-
Src-dependent changes in beta-catenin activity promote a migratory phenotype in endocrine-resistant breast cancer cells
-
A. Wadhawan, P. Barrett-Lee, C. Smith, R. I. Nicholson and S. Hiscox: Src-Dependent Changes in Beta-Catenin Activity Promote a Migratory Phenotype in Endocrine-Resistant Breast Cancer Cells. Cancer Research, 69(S), 5143, (2009)
-
(2009)
Cancer Research
, vol.69
, Issue.S
, pp. 5143
-
-
Wadhawan, A.1
Barrett-Lee, P.2
Smith, C.3
Nicholson, R.I.4
Hiscox, S.5
-
26
-
-
70349142286
-
Tyrosine-phosphorylation of the 12th armadillo-repeat of beta-catenin is associated with cadherin dysfunction in human cancer
-
K. Shomori, A. Ochiai, S. Akimoto, Y. Ino, K. Shudo, H. Ito and S. Hirohashi: Tyrosine-phosphorylation of the 12th armadillo-repeat of beta-catenin is associated with cadherin dysfunction in human cancer. Int J Oncol, 35(3), 517-524, (2009)
-
(2009)
Int J Oncol
, vol.35
, Issue.3
, pp. 517-524
-
-
Shomori, K.1
Ochiai, A.2
Akimoto, S.3
Ino, Y.4
Shudo, K.5
Ito, H.6
Hirohashi, S.7
-
27
-
-
79959618833
-
Inhibition of Src kinase restores cell-cell adhesion and suppresses the aggressive phenotype of endocrine-resistant breast cancer cells
-
Sumbitted
-
A. Wadhawan, C. Smith, N. J. Jordan, P. Barrett-Lee and S. Hiscox: Inhibition of Src kinase restores cell-cell adhesion and suppresses the aggressive phenotype of endocrine-resistant breast cancer cells. Breast Cancer Res, Sumbitted, (2008)
-
(2008)
Breast Cancer Res
-
-
Wadhawan, A.1
Smith, C.2
Jordan, N.J.3
Barrett-Lee, P.4
Hiscox, S.5
-
28
-
-
33744791463
-
Wnt signaling: Is the party in the nucleus?
-
DOI 10.1101/gad.1424006
-
K. Willert and K. A. Jones: Wnt signaling: is the party in the nucleus? Genes Dev, 20(11), 1394-1404, (2006) (Pubitemid 43830647)
-
(2006)
Genes and Development
, vol.20
, Issue.11
, pp. 1394-1404
-
-
Willert, K.1
Jones, K.A.2
-
29
-
-
79959574626
-
Reduction of in vitro metastatic potential of tamoxifenresistant breast cancer cells following inhibition of src kinase activity by AZD0530
-
S. Hiscox, L. Morgan, T. Green and R. I. Nicholson: Reduction of in vitro metastatic potential of tamoxifenresistant breast cancer cells following inhibition of src kinase activity by AZD0530. Eur J Cancer, 2(8), 121-122, (2004)
-
(2004)
Eur J Cancer
, vol.2
, Issue.8
, pp. 121-122
-
-
Hiscox, S.1
Morgan, L.2
Green, T.3
Nicholson, R.I.4
-
30
-
-
34249776956
-
Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells
-
DOI 10.1007/s10585-007-9065-y
-
S. Hiscox, N. J. Jordan, L. Morgan, T. P. Green and R. I. Nicholson: Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. Clin Exp Metastasis, 24(3), 157-167, (2007) (Pubitemid 46850227)
-
(2007)
Clinical and Experimental Metastasis
, vol.24
, Issue.3
, pp. 157-167
-
-
Hiscox, S.1
Jordan, N.J.2
Morgan, L.3
Green, T.P.4
Nicholson, R.I.5
-
31
-
-
79959594043
-
CD44-Activated HER-2 Signalling in Tamoxifen Resistant Breast Cancer Cells Promotes a Migratory Phenotype
-
B. Baruha, P. Barrett-Lee, C. Smith, R. I. Nicholson and S. Hiscox: CD44-Activated HER-2 Signalling in Tamoxifen Resistant Breast Cancer Cells Promotes a Migratory Phenotype. Cancer Res, 69(S), 5472, (2009)
-
(2009)
Cancer Res
, vol.69
, Issue.S
, pp. 5472
-
-
Baruha, B.1
Barrett-Lee, P.2
Smith, C.3
Nicholson, R.I.4
Hiscox, S.5
-
32
-
-
0038386685
-
Epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland
-
DOI 10.1186/bcr615
-
S. Z. Haslam and T. L. Woodward: Host microenvironment in breast cancer development: epithelialcell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland. Breast Cancer Res, 5(4), 208-215, (2003) (Pubitemid 36818163)
-
(2003)
Breast Cancer Research
, vol.5
, Issue.4
, pp. 208-215
-
-
Haslam, S.Z.1
Woodward, T.L.2
-
33
-
-
45449098301
-
Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas
-
V. Folgiero, P. Avetrani, G. Bon, S. E. Di Carlo, A. Fabi, C. Nistico, P. Vici, E. Melucci, S. Buglioni, L. Perracchio, I. Sperduti, L. Rosano, A. Sacchi, M. Mottolese and R. Falcioni: Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas. PLoS ONE, 3(2), e1592, (2008)
-
(2008)
PLoS ONE
, vol.3
, Issue.2
-
-
Folgiero, V.1
Avetrani, P.2
Bon, G.3
Di Carlo, S.E.4
Fabi, A.5
Nistico, C.6
Vici, P.7
Melucci, E.8
Buglioni, S.9
Perracchio, L.10
Sperduti, I.11
Rosano, L.12
Sacchi, A.13
Mottolese, M.14
Falcioni, R.15
-
34
-
-
33846554255
-
Focal adhesion kinase: A potential target in cancer therapy
-
M. J. van Nimwegen and B. van de Water: Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol, 73(5), 597-609, (2007)
-
(2007)
Biochem Pharmacol
, vol.73
, Issue.5
, pp. 597-609
-
-
Van Nimwegen, M.J.1
Van De Weter, B.2
-
35
-
-
43249102446
-
Analyzing FAK and Pyk2 in early integrin signaling events
-
Chapter 14Unit 14
-
J. A. Bernard-Trifilo, S. T. Lim, S. Hou, D. D. Schlaepfer and D. Ilic: Analyzing FAK and Pyk2 in early integrin signaling events. Curr Protoc Cell Biol, Chapter 14Unit 14 17, (2006)
-
(2006)
Curr Protoc Cell Biol
, vol.17
-
-
Bernard-Trifilo, J.A.1
Lim, S.T.2
Hou, S.3
Schlaepfer, D.D.4
Ilic, D.5
-
36
-
-
0029739950
-
Control of adhesion-dependent cell survival by focal adhesion kinase
-
S. M. Frisch, K. Vuori, E. Ruoslahti and P. Y. Chan-Hui: Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol, 134(3), 793-799, (1996) (Pubitemid 26269148)
-
(1996)
Journal of Cell Biology
, vol.134
, Issue.3
, pp. 793-799
-
-
Frisch, S.M.1
Vuori, K.2
Ruoslahti, E.3
Chan-Hui, P.-Y.4
-
37
-
-
0037416174
-
Differential regulation of cell motility and invasion by FAK
-
DOI 10.1083/jcb.200212114
-
D. A. Hsia, S. K. Mitra, C. R. Hauck, D. N. Streblow, J. A. Nelson, D. Ilic, S. Huang, E. Li, G. R. Nemerow, J. Leng, K. S. Spencer, D. A. Cheresh and D. D. Schlaepfer: Differential regulation of cell motility and invasion by FAK. J Cell Biol, 160(5), 753-767, (2003) (Pubitemid 36298270)
-
(2003)
Journal of Cell Biology
, vol.160
, Issue.5
, pp. 753-767
-
-
Hsia, D.A.1
Mitra, S.K.2
Hauck, C.R.3
Streblow, D.N.4
Nelson, J.A.5
Ilic, D.6
Huang, S.7
Li, E.8
Nemerow, G.R.9
Leng, J.10
Spencer, K.S.R.11
Cheresh, D.A.12
Schlaepfer, D.D.13
-
38
-
-
19644388523
-
Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation
-
DOI 10.1158/0008-5472.CAN-04-4126
-
M. J. van Nimwegen, S. Verkoeijen, L. van Buren, D. Burg and B. van de Water: Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res, 65(11), 4698-4706, (2005) (Pubitemid 40740806)
-
(2005)
Cancer Research
, vol.65
, Issue.11
, pp. 4698-4706
-
-
Van Nimwegen, M.J.1
Verkoeijen, S.2
Van Buren, L.3
Burg, D.4
Van De Water, B.5
-
39
-
-
27144545759
-
Specific induction of pp125 focal adhesion kinase in human breast cancer
-
DOI 10.1038/sj.bjc.6602744, PII 6602744
-
D. O. Watermann, B. Gabriel, M. Jager, M. Orlowska-Volk, A. Hasenburg, A. zur Hausen, G. Gitsch and E. Stickeler: Specific induction of pp125 focal adhesion kinase in human breast cancer. Br J Cancer, 93(6), 694-698, (2005) (Pubitemid 41486461)
-
(2005)
British Journal of Cancer
, vol.93
, Issue.6
, pp. 694-698
-
-
Watermann, D.O.1
Gabriel, B.2
Jager, M.3
Orlowska-Volk, M.4
Hasenburg, A.5
Zur Hausen, A.6
Gitsch, G.7
Stickeler, E.8
-
40
-
-
0037237066
-
Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: Immunohistochemistry and real-time PCR analyses
-
A. L. Lark, C. A. Livasy, B. Calvo, L. Caskey, D. T. Moore, X. Yang and W. G. Cance: Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin Cancer Res, 9(1), 215-222, (2003) (Pubitemid 36109736)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.1
, pp. 215-222
-
-
Lark, A.L.1
Livasy, C.A.2
Calvo, B.3
Caskey, L.4
Moore, D.T.5
Yang, X.6
Cance, W.G.7
-
41
-
-
0242491536
-
Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx
-
DOI 10.1097/00005537-200311000-00017
-
M. S. Aronsohn, H. M. Brown, G. Hauptman and L. J. Kornberg: Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Laryngoscope, 113(11), 1944-1948, (2003) (Pubitemid 37409682)
-
(2003)
Laryngoscope
, vol.113
, Issue.11
, pp. 1944-1948
-
-
Aronsohn, M.S.1
Brown, H.M.2
Hauptman, G.3
Kornberg, L.J.4
-
42
-
-
24944531575
-
High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype
-
DOI 10.1038/modpathol.3800424, PII 3800424
-
A. L. Lark, C. A. Livasy, L. Dressler, D. T. Moore, R. C. Millikan, J. Geradts, M. Iacocca, D. Cowan, D. Little, R. J. Craven and W. Cance: High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod Pathol, 18(10), 1289-1294, (2005) (Pubitemid 41348647)
-
(2005)
Modern Pathology
, vol.18
, Issue.10
, pp. 1289-1294
-
-
Lark, A.L.1
Livasy, C.A.2
Dressler, L.3
Moore, D.T.4
Millikan, R.C.5
Geradts, J.6
Iacocca, M.7
Cowan, D.8
Little, D.9
Craven, R.J.10
Cance, W.11
-
43
-
-
29044442658
-
Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma
-
DOI 10.1016/j.humpath.2005.09.024, PII S0046817705005319
-
R. Madan, M. B. Smolkin, R. Cocker, R. Fayyad and M. H. Oktay: Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Hum Pathol, 37(1), 9-15, (2006) (Pubitemid 41790497)
-
(2006)
Human Pathology
, vol.37
, Issue.1
, pp. 9-15
-
-
Madan, R.1
Smolkin, M.B.2
Cocker, R.3
Fayyad, R.4
Oktay, M.H.5
-
44
-
-
79952773417
-
Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells
-
Mar 31. [Epub ahead of print]
-
S. Hiscox, P. Barnfather, E. Hayes, P. Bramble, J. Christensen, R. I. Nicholson and P. Barrett-Lee: Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells. Breast Cancer Res Treat, 2010 Mar 31. [Epub ahead of print]
-
(2010)
Breast Cancer Res Treat
-
-
Hiscox, S.1
Barnfather, P.2
Hayes, E.3
Bramble, P.4
Christensen, J.5
Nicholson, R.I.6
Barrett-Lee, P.7
-
45
-
-
34447276000
-
Tumor microenvironment: The role of the tumor stroma in cancer
-
DOI 10.1002/jcb.21159
-
H. Li, X. Fan and J. Houghton: Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem, 101(4), 805-815, (2007) (Pubitemid 47040863)
-
(2007)
Journal of Cellular Biochemistry
, vol.101
, Issue.4
, pp. 805-815
-
-
Li, H.1
Fan, X.2
Houghton, J.3
-
46
-
-
12344328353
-
Tumor-stroma interactions
-
DOI 10.1016/j.gde.2004.12.003, PII S0959437X04001893, Oncogenes and Cell Proliferation
-
N. A. Bhowmick and H. L. Moses: Tumor-stroma interactions. Curr Opin Genet Dev, 15(1), 97-101, (2005) (Pubitemid 40127637)
-
(2005)
Current Opinion in Genetics and Development
, vol.15
, Issue.1
, pp. 97-101
-
-
Bhowmick, N.A.1
Moses, H.L.2
-
47
-
-
9244227134
-
Stromal fibroblasts in cancer initiation and progression
-
DOI 10.1038/nature03096
-
N. A. Bhowmick, E. G. Neilson and H. L. Moses: Stromal fibroblasts in cancer initiation and progression. Nature, 432(7015), 332-337, (2004) (Pubitemid 39551661)
-
(2004)
Nature
, vol.432
, Issue.7015
, pp. 332-337
-
-
Bhowmick, N.A.1
Neilson, E.G.2
Moses, H.L.3
-
48
-
-
44449151030
-
Drug development of MET inhibitors: Targeting oncogene addiction and expedience
-
DOI 10.1038/nrd2530, PII NRD2530
-
P. M. Comoglio, S. Giordano and L. Trusolino: Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov, 7(6), 504-516, (2008) (Pubitemid 351767118)
-
(2008)
Nature Reviews Drug Discovery
, vol.7
, Issue.6
, pp. 504-516
-
-
Comoglio, P.M.1
Giordano, S.2
Trusolino, L.3
-
49
-
-
0141566669
-
Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET
-
W. G. Jiang, D. Grimshaw, T. A. Martin, G. Davies, C. Parr, G. Watkins, J. Lane, R. Abounader, J. Laterra and R. E. Mansel: Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET. Clin Cancer Res, 9(11), 4274-4281, (2003) (Pubitemid 37204049)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.11
, pp. 4274-4281
-
-
Jiang, W.G.1
Grimshaw, D.2
Martin, T.A.3
Davies, G.4
Parr, C.5
Watkins, G.6
Lane, J.7
Abounader, R.8
Laterra, J.9
Mansel, R.E.10
-
50
-
-
79959586534
-
Increased matrix metalloproteinae (MMP) expression in anti-oestrogen resistant breast carcinoma cell lines
-
Y. Khirwadkar, N. Jordan, S. Hiscox and R. Nicholcon: Increased matrix metalloproteinae (MMP) expression in anti-oestrogen resistant breast carcinoma cell lines. Eur J Cancer, 3P19, (2005)
-
(2005)
Eur J Cancer
, vol.3
, pp. 19
-
-
Khirwadkar, Y.1
Jordan, N.2
Hiscox, S.3
Nicholcon, R.4
-
51
-
-
19944399371
-
C-met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu
-
DOI 10.1002/ijc.20598
-
E. Lengyel, D. Prechtel, J. H. Resau, K. Gauger, A. Welk, K. Lindemann, G. Salanti, T. Richter, B. Knudsen, G. F. Vande Woude and N. Harbeck: C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu. Int J Cancer, 113(4), 678-682, (2005) (Pubitemid 40038747)
-
(2005)
International Journal of Cancer
, vol.113
, Issue.4
, pp. 678-682
-
-
Lengyel, E.1
Prechtel, D.2
Resau, J.H.3
Gauger, K.4
Welk, A.5
Lindemann, K.6
Salanti, G.7
Richter, T.8
Knudsen, B.9
Vande Woude, G.F.10
Harbeck, N.11
-
52
-
-
0036595629
-
Epithelial-mesenchymal transitions in tumour progression
-
J. P. Thiery: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer, 2(6), 442-454, (2002)
-
(2002)
Nat Rev Cancer
, vol.2
, Issue.6
, pp. 442-454
-
-
Thiery, J.P.1
-
53
-
-
0032523074
-
Expression of c-met is a strong independent prognostic factor in breast carcinoma
-
DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0. CO;2-7
-
R. A. Ghoussoub, D. A. Dillon, T. D'Aquila, E. B. Rimm, E. R. Fearon and D. L. Rimm: Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer, 82(8), 1513-1520, (1998) (Pubitemid 28164998)
-
(1998)
Cancer
, vol.82
, Issue.8
, pp. 1513-1520
-
-
Ghoussoub, R.A.D.1
Dillon, D.A.2
D'Aquila, T.3
Rimm, E.B.4
Fearon, E.R.5
Rimm, D.L.6
-
54
-
-
11144324910
-
Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells
-
DOI 10.1152/ajprenal.00318.2003
-
X. Zhang, J. Yang, Y. Li and Y. Liu: Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells. Am J Physiol Renal Physiol, 288(1), F16-26, (2005) (Pubitemid 40038672)
-
(2005)
American Journal of Physiology - Renal Physiology
, vol.288
, Issue.1-57
-
-
Zhang, X.1
Yang, J.2
Li, Y.3
Liu, Y.4
-
55
-
-
0037216445
-
Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney
-
X. Zhang, Y. Li, C. Dai, J. Yang, P. Mundel and Y. Liu: Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney. Am J Physiol Renal Physiol, 284(1), F82-94, (2003) (Pubitemid 35471288)
-
(2003)
American Journal of Physiology - Renal Physiology
, vol.284
, Issue.1-53
-
-
Zhang, X.1
Li, Y.2
Dai, C.3
Yang, J.4
Mundel, P.5
Liu, Y.6
-
56
-
-
15544365184
-
Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by flourescence resonance energy transfer
-
DOI 10.1210/me.2004-0326
-
K. Kim, R. Barhoumi, R. Burghardt and S. Safe: Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer. Mol Endocrinol, 19(4), 843-854, (2005) (Pubitemid 40403092)
-
(2005)
Molecular Endocrinology
, vol.19
, Issue.4
, pp. 843-854
-
-
Kim, K.1
Barhoumi, R.2
Burghardt, R.3
Safe, S.4
-
57
-
-
12844287625
-
Sp1 transcription factor expression is regulated by estrogen-related receptor alpha1
-
DOI 10.1016/j.bbrc.2004.12.165, PII S0006291X04029961
-
D. Sumi and L. J. Ignarro: Sp1 transcription factor expression is regulated by estrogen-related receptor alpha1. Biochem Biophys Res Commun, 328(1), 165-172, (2005) (Pubitemid 40164650)
-
(2005)
Biochemical and Biophysical Research Communications
, vol.328
, Issue.1
, pp. 165-172
-
-
Sumi, D.1
Ignarro, L.J.2
-
58
-
-
13544271667
-
Waf1 gene transcription through releasing histone deacetylase 1 and betrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line
-
DOI 10.1074/jbc.M408063200
-
R. Varshochi, F. Halim, A. Sunters, J. P. Alao, P. A. Madureira, S. M. Hart, S. Ali, D. M. Vigushin, R. C. Coombes and E. W. Lam: ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line. J Biol Chem, 280(5), 3185-3196, (2005) (Pubitemid 40223780)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.5
, pp. 3185-3196
-
-
Varshochi, R.1
Halim, F.2
Sunters, A.3
Alao, J.P.4
Madureira, P.A.5
Hart, S.M.6
Ali, S.7
Vigushin, D.M.8
Coombes, R.C.9
Lam, E.W.-F.10
-
59
-
-
34948870439
-
Upregulation of CD44s and variants in anti-hormone resistant breast cancer cells
-
M. E. Harper, C. Smith and R. I. Nicholson: Upregulation of CD44s and variants in anti-hormone resistant breast cancer cells. Eur J Cancer, 3A71, (2005)
-
(2005)
Eur J Cancer
, vol.3 A71
-
-
Harper, M.E.1
Smith, C.2
Nicholson, R.I.3
-
60
-
-
0027065573
-
Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
-
DOI 10.1073/pnas.89.24.12160
-
G. R. Screaton, M. V. Bell, D. G. Jackson, F. B. Cornelis, U. Gerth and J. I. Bell: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A, 89(24), 12160-12164, (1992) (Pubitemid 23004805)
-
(1992)
Proceedings of the National Academy of Sciences of the United States of America
, vol.89
, Issue.24
, pp. 12160-12164
-
-
Screaton, G.R.1
Bell, M.V.2
Jackson, D.G.3
Cornelis, F.B.4
Gerth, U.5
Bell, J.I.6
-
61
-
-
1242285621
-
The role of CD44v3 expression in female breast carcinomas
-
J. Rys, A. Kruczak, B. Lackowska, A. Jaszcz-Gruchala, A. Brandys, A. Stelmach and M. Reinfuss: The role of CD44v3 expression in female breast carcinomas. Pol J Pathol, 54(4), 243-247, (2003) (Pubitemid 38233129)
-
(2003)
Polish Journal of Pathology
, vol.54
, Issue.4
, pp. 243-247
-
-
Rys, J.1
Kruczak, A.2
Lackowska, B.3
Jaszcz-Gruchala, A.4
Brandys, A.5
Stelmach, A.6
Reinfuss, M.7
-
62
-
-
53749085227
-
Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients
-
S. Mayer, A. Zur Hausen, D. O. Watermann, S. Stamm, M. Jager, G. Gitsch and E. Stickeler: Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients. J Cancer Res Clin Oncol, (2008)
-
(2008)
J Cancer Res Clin Oncol
-
-
Mayer, S.1
Zur Hausen, A.2
Watermann, D.O.3
Stamm, S.4
Jager, M.5
Gitsch, G.6
Stickeler, E.7
-
63
-
-
18544364014
-
Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer
-
O. Watanabe, J. Kinoshita, T. Shimizu, H. Imamura, A. Hirano, T. Okabe, M. Aiba and K. Ogawa: Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer. J Exp Clin Cancer Res, 24(1), 75-82, (2005) (Pubitemid 40655866)
-
(2005)
Journal of Experimental and Clinical Cancer Research
, vol.24
, Issue.1
, pp. 75-82
-
-
Watanabe, O.1
Kinoshita, J.2
Shimizu, T.3
Imamura, H.4
Hirano, A.5
Okabe, T.6
Aiba, M.7
Ogawa, K.8
-
64
-
-
13244261126
-
Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast
-
DOI 10.1111/j.1365-2559.2004.01981.x
-
Y. Gong, X. Sun, L. Huo, E. L. Wiley and M. S. Rao: Expression of cell adhesion molecules, CD44s and Ecadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Histopathology, 46(1), 24-30, (2005) (Pubitemid 40193694)
-
(2005)
Histopathology
, vol.46
, Issue.1
, pp. 24-30
-
-
Gong, Y.1
Sun, X.2
Huo, L.3
Wiley, E.L.4
Rao, M.S.5
-
65
-
-
38349026544
-
In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver
-
A. Ouhtit, Z. Y. Abd Elmageed, M. E. Abdraboh, T. F. Lioe and M. H. Raj: In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. Am J Pathol, 171(6), 2033-2039, (2007)
-
(2007)
Am J Pathol
, vol.171
, Issue.6
, pp. 2033-2039
-
-
Ouhtit, A.1
Abd Elmageed, Z.Y.2
Abdraboh, M.E.3
Lioe, T.F.4
Raj, M.H.5
-
66
-
-
79959617446
-
Overexpression of CD44 accompanies acquired tamoxifen resistance and potentiates Her2 invasive signaling
-
L. Goddard, N. Jordan, C. Smith, R. I. Nicholson and S. Hiscox: Overexpression of CD44 accompanies acquired tamoxifen resistance and potentiates Her2 invasive signaling. Submitted, (2008)
-
(2008)
Submitted
-
-
Goddard, L.1
Jordan, N.2
Smith, C.3
Nicholson, R.I.4
Hiscox, S.5
-
67
-
-
79959610820
-
CD44 is overexpressed in fulvestrant-resistant breast cancer cells: Potentiation of response to HGF
-
N. J. Jordan, C. Smith, J. Gee, R. I. Nicholson and S. Hiscox: CD44 is overexpressed in fulvestrant-resistant breast cancer cells: potentiation of response to HGF. Submitted, (2008)
-
(2008)
Submitted
-
-
Jordan, N.J.1
Smith, C.2
Gee, J.3
Nicholson, R.I.4
Hiscox, S.5
-
68
-
-
79959614434
-
Overexpression of CD44 augments tamoxifen-resistant breast cancer cell response to heregulin
-
S. Hiscox, N. J. Jordan, L. Goddard, C. Smith, M. Harper, J. Gee and R. Nicholson: Overexpression of CD44 augments tamoxifen-resistant breast cancer cell response to heregulin. Breast Caner Research, 10(2), S19, (2008)
-
(2008)
Breast Caner Research
, vol.10
, Issue.2
-
-
Hiscox, S.1
Jordan, N.J.2
Goddard, L.3
Smith, C.4
Harper, M.5
Gee, J.6
Nicholson, R.7
-
69
-
-
0030783518
-
Interaction between the adhesion receptor, CD44, and the oncogene product, p185(HER2), promotes human ovarian tumor cell activation
-
DOI 10.1074/jbc.272.44.27913
-
L. Y. Bourguignon, H. Zhu, A. Chu, N. Iida, L. Zhang and M. C. Hung: Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem, 272(44), 27913-27918, (1997) (Pubitemid 27473595)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.44
, pp. 27913-27918
-
-
Bourguignon, L.Y.W.1
Zhu, H.2
Chu, A.3
Iida, N.4
Zhang, L.5
Hung, M.-C.6
-
70
-
-
0036342722
-
EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines
-
D. Tsatas, V. Kanagasundaram, A. Kaye and U. Novak: EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines. J Clin Neurosci, 9(3), 282-288, (2002)
-
(2002)
J Clin Neurosci
, vol.9
, Issue.3
, pp. 282-288
-
-
Tsatas, D.1
Kanagasundaram, V.2
Kaye, A.3
Novak, U.4
-
71
-
-
44749090941
-
Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells
-
B. P. Toole and M. G. Slomiany: Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol, 18(4), 244-250, (2008)
-
(2008)
Semin Cancer Biol
, vol.18
, Issue.4
, pp. 244-250
-
-
Toole, B.P.1
Slomiany, M.G.2
-
72
-
-
33744767934
-
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
-
S. Hiscox, L. Morgan, T. P. Green, D. Barrow, J. Gee and R. I. Nicholson: Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells. Breast Cancer Res Treat 1-12, (2005)
-
(2005)
Breast Cancer Res Treat
, pp. 1-12
-
-
Hiscox, S.1
Morgan, L.2
Green, T.P.3
Barrow, D.4
Gee, J.5
Nicholson, R.I.6
-
73
-
-
31044447246
-
Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer
-
DOI 10.1016/j.bbrc.2005.12.164, PII S0006291X05029128
-
M. D. Planas-Silva, R. D. Bruggeman, R. T. Grenko and J. Stanley Smith: Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer. Biochem Biophys Res Commun, 341(1), 73-81, (2006) (Pubitemid 43118368)
-
(2006)
Biochemical and Biophysical Research Communications
, vol.341
, Issue.1
, pp. 73-81
-
-
Planas-Silva, M.D.1
Bruggeman, R.D.2
Grenko, R.T.3
Stanley Smith, J.4
-
74
-
-
34547134493
-
Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer
-
DOI 10.1172/JCI21739
-
I. Chu, A. Arnaout, S. Loiseau, J. Sun, A. Seth, C. McMahon, K. Chun, B. Hennessy, G. B. Mills, Z. Nawaz and J. M. Slingerland: Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer. J Clin Invest, 117(8), 2205-2215, (2007) (Pubitemid 47219565)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.8
, pp. 2205-2215
-
-
Chu, I.1
Arnaout, A.2
Loiseau, S.3
Sun, J.4
Seth, A.5
McMahon, C.6
Chun, K.7
Hennessy, B.8
Mills, G.B.9
Nawaz, Z.10
Slingerland, J.M.11
-
75
-
-
33847023585
-
Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells
-
P. Fan, J. Wang, R. J. Santen and W. Yue: Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. Cancer Res, 67(3), 1352-1360, (2007)
-
(2007)
Cancer Res
, vol.67
, Issue.3
, pp. 1352-1360
-
-
Fan, P.1
Wang, J.2
Santen, R.J.3
Yue, W.4
-
76
-
-
79959624148
-
-
J. S. Biscardi, D. A. Tice and S. J. Parsons: c-Src, receptor tyrosine kinases, and human cancer. 7661-+, (1999)
-
(1999)
C-Src, Receptor Tyrosine Kinases, and Human Cancer
, pp. 7661
-
-
Biscardi, J.S.1
Tice, D.A.2
Parsons, S.J.3
-
78
-
-
0037088647
-
-
L. Moro, L. Dolce, S. Cabodi, E. Bergatto, E. B. Erba, M. Smeriglio, E. Turco, S. F. Retta, M. G. Giuffrida, M. Venturino, J. Godovac-Zimmermann, A. Conti, E. Schaefer, L. Beguinot, C. Tacchetti, P. Gaggini, L. Silengo, G. Tarone and P. Defilippi: Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. 277(11), 9405-9414, (2002)
-
(2002)
Integrin-induced Epidermal Growth Factor (EGF) Receptor Activation Requires C-Src and p130Cas and Leads to Phosphorylation of Specific EGF Receptor Tyrosines.
, vol.277
, Issue.11
, pp. 9405-9414
-
-
Moro, L.1
Dolce, L.2
Cabodi, S.3
Bergatto, E.4
Erba, E.B.5
Smeriglio, M.6
Turco, E.7
Retta, S.F.8
Giuffrida, M.G.9
Venturino, M.10
Godovac-Zimmermann, J.11
Conti, A.12
Schaefer, E.13
Beguinot, L.14
Tacchetti, C.15
Gaggini, P.16
Silengo, L.17
Tarone, G.18
Defilippi, P.19
-
79
-
-
3042715237
-
-
V. G. Brunton, I. R. J. MacPherson and M. C. Frame: Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry. 1692(2-3), 121-144, (2004)
-
(2004)
Cell Adhesion Receptors, Tyrosine Kinases and Actin Modulators: A Complex Three-way Circuitry
, vol.1692
, Issue.2-3
, pp. 121-144
-
-
Brunton, V.G.1
MacPherson, I.R.J.2
Frame, M.C.3
-
81
-
-
33846870586
-
Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer
-
DOI 10.1677/erc.1.01297
-
S. Hiscox, L. Morgan, T. Green and R. I. Nicholson: Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer. Endocr Relat Cancer, 13 Suppl 1S53-59, (2006) (Pubitemid 46222445)
-
(2006)
Endocrine-Related Cancer
, vol.13
, Issue.SUPPL. 1
-
-
Hiscox, S.1
Morgan, L.2
Green, T.3
Nicholson, R.I.4
-
82
-
-
0038386613
-
Src family kinases in tumor progression and metastasis
-
DOI 10.1023/A:1023772912750
-
J. M. Summy and G. E. Gallick: Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev, 22(4), 337-358, (2003) (Pubitemid 36791891)
-
(2003)
Cancer and Metastasis Reviews
, vol.22
, Issue.4
, pp. 337-358
-
-
Summy, J.M.1
Gallick, G.E.2
-
83
-
-
33745402375
-
-
S. Hiscox, L. Morgan, T. P. Green, D. Barrow, J. Gee and R. I. Nicholson: Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells. 97(3), 263-274, (2006)
-
(2006)
Elevated Src Activity Promotes Cellular Invasion and Motility in Tamoxifen Resistant Breast Cancer Cells
, vol.97
, Issue.3
, pp. 263-274
-
-
Hiscox, S.1
Morgan, L.2
Green, T.P.3
Barrow, D.4
Gee, J.5
Nicholson, R.I.6
-
84
-
-
33644532202
-
-
A. M. L. Coluccia, D. Benati, H. Dekhil, A. De Filippo, C. Lan and C. Gambacorti-Passerini: SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling. 66(4), 2279-2286, (2006)
-
(2006)
SKI-606 Decreases Growth and Motility of Colorectal Cancer Cells by Preventing pp60(c-Src)-dependent Tyrosine Phosphorylation of Beta-catenin and Its Nuclear Signaling.
, vol.66
, Issue.4
, pp. 2279-2286
-
-
Coluccia, A.M.L.1
Benati, D.2
Dekhil, H.3
De Filippo, A.4
Lan, C.5
Gambacorti-Passerini, C.6
-
85
-
-
24644447079
-
The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin
-
DOI 10.1016/j.ceb.2005.08.009, PII S0955067405001122
-
J. Lilien and J. Balsamo: The regulation of cadherinmediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol, 17(5), 459-465, (2005) (Pubitemid 41267159)
-
(2005)
Current Opinion in Cell Biology
, vol.17
, Issue.5 SPEC. ISS.
, pp. 459-465
-
-
Lilien, J.1
Balsamo, J.2
-
86
-
-
34249776956
-
-
S. Hiscox, N. J. Jordan, L. Morgan, T. P. Green and R. I. Nicholson: Src kinase promotes adhesionindependent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. 24(3), 157-167, (2007)
-
(2007)
Src Kinase Promotes Adhesionindependent Activation of FAK and Enhances Cellular Migration in Tamoxifen-resistant Breast Cancer Cells.
, vol.24
, Issue.3
, pp. 157-167
-
-
Hiscox, S.1
Jordan, N.J.2
Morgan, L.3
Green, T.P.4
Nicholson, R.I.5
-
87
-
-
33748286819
-
Integrin-regulated FAK-Src signaling in normal and cancer cells
-
DOI 10.1016/j.ceb.2006.08.011, PII S0955067406001220
-
S. K. Mitra and D. D. Schlaepfer: Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol, 18(5), 516-523, (2006) (Pubitemid 44332916)
-
(2006)
Current Opinion in Cell Biology
, vol.18
, Issue.5
, pp. 516-523
-
-
Mitra, S.K.1
Schlaepfer, D.D.2
-
88
-
-
33645072205
-
Treatment for advanced tumors: SRC reclaims center stage
-
J. M. Summy and G. E. Gallick: Treatment for advanced tumors: SRC reclaims center stage. Clin Cancer Res, 12(5), 1398-1401, (2006)
-
(2006)
Clin Cancer Res
, vol.12
, Issue.5
, pp. 1398-1401
-
-
Summy, J.M.1
Gallick, G.E.2
-
89
-
-
33644647192
-
Inhibition of Src expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
-
DOI 10.2353/ajpath.2006.050570
-
J. G. Trevino, J. M. Summy, D. P. Lesslie, N. U. Parikh, D. S. Hong, F. Y. Lee, N. J. Donato, J. L. Abbruzzese, C. H. Baker and G. E. Gallick: Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol, 168(3), 962-972, (2006) (Pubitemid 43327748)
-
(2006)
American Journal of Pathology
, vol.168
, Issue.3
, pp. 962-972
-
-
Trevino, J.G.1
Summy, J.M.2
Lesslie, D.P.3
Parikh, N.U.4
Hong, D.S.5
Lee, F.Y.6
Donato, N.J.7
Abbruzzese, J.L.8
Baker, C.H.9
Gallick, G.E.10
-
90
-
-
33749003219
-
Antiangiogenic and antitumor effects of Src inhibition in ovarian carcinoma
-
DOI 10.1158/0008-5472.CAN-06-1410
-
L. Y. Han, C. N. Landen, J. G. Trevino, J. Halder, Y. G. Lin, A. A. Kamat, T. J. Kim, W. M. Merritt, R. L. Coleman, D. M. Gershenson, W. C. Shakespeare, Y. Wang, R. Sundaramoorth, C. A. Metcalf, 3rd, D. C. Dalgarno, T. K. Sawyer, G. E. Gallick and A. K. Sood: Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma. Cancer Res, 66(17), 8633-8639, (2006) (Pubitemid 44449178)
-
(2006)
Cancer Research
, vol.66
, Issue.17
, pp. 8633-8639
-
-
Han, L.Y.1
Landen, C.N.2
Trevino, J.G.3
Halder, J.4
Lin, Y.G.5
Kamat, A.A.6
Kim, T.-J.7
Merritt, W.M.8
Coleman, R.L.9
Gershenson, D.M.10
Shakespeare, W.C.11
Wang, Y.12
Sundaramoorth, R.13
Metcalf III, C.A.14
Dalgarno, D.C.15
Sawyer, T.K.16
Gallick, G.E.17
Sood, A.K.18
-
91
-
-
33748953871
-
The novel Src kinase inhibitor M475271 inhibits VEGF-induced vascular endothelial-cadherin and beta-catenin phosphorylation but increases their association
-
DOI 10.1254/jphs.FP0060357
-
N. Ali, M. Yoshizumi, S. Yano, S. Sone, H. Ohnishi, K. Ishizawa, Y. Kanematsu, K. Tsuchiya and T. Tamaki: The novel Src kinase inhibitor M475271 inhibits VEGFinduced vascular endothelial-cadherin and beta-catenin phosphorylation but increases their association. J Pharmacol Sci, 102(1), 112-120, (2006) (Pubitemid 44440974)
-
(2006)
Journal of Pharmacological Sciences
, vol.102
, Issue.1
, pp. 112-120
-
-
Ali, N.1
Yoshizumi, M.2
Yano, S.3
Sone, S.4
Ohnishi, H.5
Ishizawa, K.6
Kanematsu, Y.7
Tsuchiya, K.8
Tamaki, T.9
|